Form 4 for IMVT Immunovant, Inc.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001140361-23-046976 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-02 | IMVT | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $38.00 | +1.53M | 79.81M | +2% | +$58.00M | |
| 2023-10-04 | 2023-10-02 | IMVT | Roivant Sciences Ltd. | Dir, 10% | A - Grant | $38.00 | +4.47M | 78.28M | +6% | +$170.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value per share | 2023-10-02 | P | A | 1,526,316 | $38.00 | 79,805,331 | D | — | — | |
| 2 | Common | Common Stock, $0.0001 par value per share | 2023-10-02 | A | A | 4,473,684 | $38.00 | 78,279,015 | D | — | — |